← Evidence map

ReviewBreast cancer (Dove Medical Press)2021

Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective.

Peng Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33658845